The antimalarial poses dangers for the military performance of the UK armed forces.
Lariam is an antimalarial drug that has a safety profile characterised by a predominance of neuropsychiatric adverse reactions. It is still prescribed within the British armed forces. A purposive survey (n = 28) of serving and ex-serving British military personnel with experience of operations where Lariam was used revealed that 82% experienced side effects and 85.71% considered the drug unsuitable for use during military operations. An additional online survey (n = 50)
Continue reading by joining RUSIView membership options
Join the World’s Leading Defence and Security Community
- A busy programme of members' only events
- Access to a suite of RUSI publications
- Access to experts, networks and research teams